Claro Advisors LLC Gilead Sciences, Inc. Transaction History

Claro Advisors LLC

$569 Million
Q2 2025

A detailed history of Claro Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Claro Advisors LLC holds 3,202 shares of GILD stock, worth $373,929. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,202

Previous 10,887 70.59%

Holding current value

$373,929

Previous $1.22 Million 70.88%

% of portfolio

0.06%

Previous 0.18%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$96.91 - $113.0 $744,753 - $868,405	-7,685 Reduced 70.59%	3,202 $355,000
Q1 2025 May 12, 2025	SELL	$89.14 - $117.41 $25,404 - $33,461	-285 Reduced 2.55%	10,887 $1.22 Million
Q4 2024 Jan 13, 2025	BUY	$83.95 - $97.9 $219,697 - $256,204	2,617 Added 30.59%	11,172 $1.03 Million
Q3 2024 Nov 07, 2024	BUY	$66.59 - $83.99 $250,112 - $315,466	3,756 Added 78.27%	8,555 $717,000
Q3 2024 Oct 17, 2024	SELL	$66.59 - $83.99 $171,069 - $215,770	-2,569 Reduced 34.87%	4,799 $402,000
Q2 2024 Jul 31, 2024	BUY	$63.15 - $72.88 $23,618 - $27,257	374 Added 5.35%	7,368 $505,000
Q1 2024 Apr 18, 2024	SELL	$71.58 - $87.29 $48,388 - $59,008	-676 Reduced 8.81%	6,994 $512,000
Q4 2023 Jan 22, 2024	SELL	$73.27 - $83.09 $40,957 - $46,447	-559 Reduced 6.79%	7,670 $621,000
Q3 2023 Oct 10, 2023	SELL	$73.94 - $80.67 $143,295 - $156,338	-1,938 Reduced 19.06%	8,229 $616,000
Q2 2023 Aug 08, 2023	BUY	$76.01 - $86.7 $167,298 - $190,826	2,201 Added 27.63%	10,167 $783,000
Q1 2023 Apr 17, 2023	BUY	$77.31 - $88.08 $214,921 - $244,862	2,780 Added 53.61%	7,966 $660,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $52,286 - $75,065	-839 Reduced 13.93%	5,186 $445,000
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $38,730 - $43,621	671 Added 12.53%	6,025 $372,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $1,102 - $1,251	17 Added 0.32%	5,354 $389,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $17,125 - $18,476	253 Added 4.98%	5,337 $373,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $952 - $1,040	-15 Reduced 0.29%	5,084 $350,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $20,340 - $23,207	339 Added 7.12%	5,099 $330,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $226 - $258	-4 Reduced 0.08%	4,760 $277,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $34,030 - $42,787	-548 Reduced 10.32%	4,764 $301,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $5,280 - $6,132	-73 Reduced 1.36%	5,312 $409,000
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $29,686 - $38,024	-474 Reduced 8.09%	5,385 $403,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $25,202 - $27,722	-409 Reduced 6.53%	5,859 $381,000
Q3 2019 Oct 29, 2019	BUY	$62.51 - $69.0 $13,502 - $14,904	216 Added 3.57%	6,268 $397,000
Q2 2019 Jul 24, 2019	SELL	$61.87 - $69.38 $16,890 - $18,940	-273 Reduced 4.32%	6,052 $409,000
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $23,948 - $26,829	-383 Reduced 5.71%	6,325 $411,000
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $406,102 - $529,932	6,708 New	6,708 $518,000

Others Institutions Holding GILD

# of Institutions

2,329

Shares Held

1.02B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $146B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.

Account

Claro Advisors LLC Gilead Sciences, Inc. Transaction History